We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Available until 12/31/2020

Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now

featured

Journal Scan / Research · August 07, 2020

Systemic or Biologic Treatment in Psoriasis Patients Does Not Increase the Risk of a Severe Form of COVID‐19

Journal of the European Academy of Dermatology and Venereology: JEADV

 

TAKE-HOME MESSAGE


abstract

This abstract is available on the publisher's site.

Access this abstract now

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Systemic or Biologic Treatment in Psoriasis Patients Does Not Increase the Risk of a Severe Form of COVID‐19
J Eur Acad Dermatol Venereol 2020 Jun 21;[EPub Ahead of Print], AC Fougerousse, M Perrussel, PA Bécherel, E Begon, V Pallure, I Zaraa, G Chaby, J Parier, M Kemula, L Mery-Bossard, C Poreaux, C Taieb, F Maccari, Z Reguiai, the GEM Resopso

Further Reading